Omlonti
Active substance: omidenepag isopropyl
SOLUTION/ DROPS · OMIDENEPAG ISOPROPYL .02 mg/mL
United StatesActive
Marketing holder: Ocuvex Therapeutics, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- OMIDENEPAG ISOPROPYL · .02 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-57c1-7477-9ad7-c628df493f95;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 84826-002
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- OPHTHALMIC
Sources
- product · openFDA NDC · 84826-002 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 84826-002 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 84826-002 · Verified 2026-10-09 · open in source